Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus Omeprazole

Bowel Diseases, Inflammatory Clinical Trial

Official title:
Double-Blind, Placebo-Controlled, Randomized Two-Week Study, Comparing Small Bowel Lesions Associated With Celecoxib (200 mg BID) vs. Ibuprofen (800 mg TID) Plus Omeprazole (20 mg QD)

Status Completed

Clinical Trial Summary

To evaluate the small bowel lesion pattern associated with celecoxib alone versus ibuprofen plus omeprazole

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00640809
Study type	Interventional
Source	Pfizer
Contact
Status	Completed
Phase	Phase 4
Start date	October 2003
Completion date	April 2004

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04587713` - Single Dose Bioavailability and Ethnobridging PK Study in Healthy Subjects	Phase 1
Completed	`NCT05043363` - LuCID - Investigating the Use of a Novel Digital Rectoscope for Community Examinations During COVID-19
Completed	`NCT02799615` - Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Completed	`NCT03408470` - TD-1473 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects	Phase 1
Not yet recruiting	`NCT02760940` - Anemia in Inflammatory Bowel Disease	Phase 4
Terminated	`NCT04032756` - Tofacitinib Registry of Patients With Ulcerative Colitis in Germany
Terminated	`NCT02255227` - Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD	Phase 2
Completed	`NCT03999294` - Bmgim Music Therapy Method in Reducing Stress in Patients With Inflammatory Bowel Disease	N/A